Affinity Asset Advisors, LLC Verona Pharma PLC Put Options Transaction History
Affinity Asset Advisors, LLC
- $579 Million
- Q3 2024
Put Options
1 transactions
Others Institutions Holding VRNA
# of Institutions
167Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$295 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$261 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$234 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$197 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$166 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.85B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...